z-logo
open-access-imgOpen Access
Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease
Author(s) -
Erica Weitzner,
Donna McKenna,
John Nowakowski,
Carol Scavarda,
Rhea L. Dornbush,
Susan Bittker,
Denise R. Cooper,
Robert B. Nadelman,
Paul Visintainer,
Ira Schwartz,
Gary P. Wormser
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ735
Subject(s) - lyme disease , medicine , erythema migrans , borrelia burgdorferi , erythema chronicum migrans , dermatology , spirochaetaceae , erythema , surgery , immunology , lyme borreliosis , antibody
Lyme disease patients with erythema migrans are said to have post-treatment Lyme disease symptoms (PTLDS) if there is persistence of subjective symptoms for at least 6 months following antibiotic treatment and resolution of the skin lesion. The purpose of this study was to characterize PTLDS in patients with culture-confirmed early Lyme disease followed for >10 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom